Clinical Trial

Effectiveness and Cost-effectiveness of Simultaneous Screening and Intervention for Antenatal Depression and Anxiety Symptoms From a Transdiagnostic Perspective: A Scale-up Feasibility Study

Completed
View on ClinicalTrials.gov →
Summary
This scale-up study aimed to explore the effectiveness of simultaneous screening and intervention of antenatal depression and anxiety in preventing postpartum depression and anxiety and how scale-up might be successfully achieved. The age was ≥18 years old pregnancy and capable of completing the independent assessment of smart phones. Exclude those with abnormal comprehension and expression abilities. The implementation group, 1. screening during pregnancy and 42 days postpartum; 2. Stratified iCBT Intervention, usual care. Low-intensity: Mild cases (EPDS≥9/GAD-7≥5) received 11 animated video sessions adapted from WHO's Thinking Healthy Programme manual. High-intensity: Moderate-severe cases (EPDS≥12/GAD-7≥10) received low-intensity components and supplemental telehealth counseling. The control group, screening at 42 days postpartum, usual care.
Trial Details
NCT Number NCT07349368
Lead Sponsor Anhui Medical University
Conditions Antenatal Depression, Antenatal Anxiety
Enrollment 3,314 participants
Start Date 2021-03-24
Primary Completion 2022-06-24 (estimated)
Study Completion 2022-06-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-16